Sierk Poetting - 22 Apr 2026 Form 4 Insider Report for BioNTech SE (BNTX)

Reporting relationship: Chief Operating Officer
Issuer ticker: BNTX
Reported as of: 22 Apr 2026
Net transaction value: -$5,527,960
SEC form: 4
Accepted by SEC: 23 Apr 2026, 16:02:44 UTC
Prior SEC filing: 18 Mar 2026
Next SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Humza Bokhari, Attorney-in-Fact

Key filing fact

Sierk Poetting filed Form 4 for BioNTech SE (BNTX) on 23 Apr 2026.

Key facts

This page summarizes Sierk Poetting's Form 4 filing for BioNTech SE (BNTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Apr 2026, 16:02.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$5,527,960.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955589 Primary reporting owner

Poetting Sierk

Relationship: Chief Operating Officer
Address: C/O BIONTECH SE, AN DER GOLDGRUBE 12, MAINZ, GERMANY
Signature: /s/ Humza Bokhari, Attorney-in-Fact
Signature date: 23 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNTX transaction

Ordinary Shares

Sale

Transaction value: $5,527,960
Shares: -50,000
Change %: -11%
Price: $110.56
Shares after: 399,387
Date: 22 Apr 2026
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The ordinary shares are held by Tofino GmbH. The Reporting Person is the sole shareholder of Tofino GmbH and may be deemed to beneficially own the ordinary shares held by Tofino GmbH.